| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Bone Marrow Transplant Program and Departments of
*
Medicine,
Biostatistics, and
Pathology, Medical College of Wisconsin, Milwaukee, WI 53226; and
National Cancer Institute, Frederick, MD 21791
Interleukin-7 has been shown to enhance T cell reconstitution after allogeneic bone marrow transplantation, in part, by expansion of mature donor T cells, but whether IL-7 also exacerbates graft-vs-host disease (GVHD) remains unresolved. To address this issue, we examined the effect of IL-7 on GVHD induction using a well-defined murine GVHD model (B6
B6AF1/J). Administration of IL-7 to nonirradiated B6AF1/J recipients of B6 T cells resulted in expansion of splenic donor CD4+ and CD8+ T cells and increased GVHD mortality. In contrast, administration of IL-7 on the same schedule failed to increase GVHD mortality in either sublethally or lethally irradiated animals that received graded doses of T cells designed to induce varying degrees of GVHD severity. Moreover, IL-7 failed to increase the number of alloreactive T cells when examined in a murine model (B6BALB.B) that allowed for direct quantitation of graft-vs-host-reactive T cells. The combination of irradiation and transplantation of alloreactive donor T cells resulted in significantly increased levels of endogenous splenic IL-7 mRNA when compared with nonirradiated transplanted animals, providing a potential explanation for why exogenous IL-7 did not increase GVHD severity in these mice. We conclude that host conditioning modulates the ability of exogenous IL-7 to exacerbate GVHD and that this occurs through induction of endogenous IL-7 production.
This article has been cited by other articles:
|
|
 |
|
  R. M. Dean, T. Fry, C. Mackall, S. M. Steinberg, F. Hakim, D. Fowler, J. Odom, J. Foley, R. Gress, and M. R. Bishop Association of Serum Interleukin-7 Levels With the Development of Acute Graft-Versus-Host Disease J. Clin. Oncol., December 10, 2008; 26(35): 5735 - 5741. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Reddy IL-7: griffinesque role in GVHD Blood, October 15, 2007; 110(8): 2788 - 2788. [Full Text] [PDF]
|
|
|
|
|
|
B. Chung, E. P. Dudl, D. Min, L. Barsky, N. Smiley, and K. I. Weinberg Prevention of graft-versus-host disease by anti IL-7R{alpha} antibody Blood, October 15, 2007; 110(8): 2803 - 2810. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E.C. Broers, M. Bruinsma, S. J. Posthumus-van Sluijs, E.-J. Wils, H. Spits, B. Lowenberg, E. Braakman, and J. J. Cornelissen IL-7 mediated protection against minor antigen-mismatched allograft rejection is associated with enhanced recovery of regulatory T cells Haematologica, August 1, 2007; 92(8): 1099 - 1106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Gorski, X. Chen, M. Gendelman, M. Yassai, A. Krueger, E. Tivol, B. Logan, R. Komorowski, S. Vodanovic-Jankovic, and W. R. Drobyski Homeostatic expansion and repertoire regeneration of donor T cells during graft versus host disease is constrained by the host environment Blood, June 15, 2007; 109(12): 5502 - 5510. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Staton, A. B. Carpenter, and S. H. Jackman IL-7 Is a Critical Factor in Modulating Lesion Development in Skn-Directed Autoimmunity J. Immunol., April 1, 2006; 176(7): 3978 - 3986. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. R Blazar and W. J Murphy Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD) Phil Trans R Soc B, September 29, 2005; 360(1461): 1747 - 1767. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
